Delivery Order SPE2DR25D2104-SPE2DR26F3TYH
Award Date 1/20/26
Potential Completion Date 1/21/26
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $25,475.56 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,230.90 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $5,224.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,720.85 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly operating as AmerisourceBergen), is...
- The Defense Logistics Agency awarded a delivery order valued at $47,448.98 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $35,688.67 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed-price structure. This competitively awarded, non-set-aside order was executed on January 16, 2026, with an ultimate completion date of January 20, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $37,071.79 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units), with completion scheduled for October 30, 2025. The contract employs firm fixed pricing with no small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $3,710.89 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Gemtesa 75 mg tablets (90-count units). This non-set-aside, competitively awarded contract carries a firm fixed-price structure with an ultimate completion date of January 9, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,091.69 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 5, 2026, with completion expected by January 6, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,822.11 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...